Tanzania is experiencing perennial stockouts of various kinds of medicines and supplies; however, short supply of ARVs in particular is catastrophic to the health of users. People with key responsibilities in the supply chain need to work efficiently and play their roles effectively so as to avoid unnecessary procurement delays.
The analysis finds that donor government funding for HIV in low- and middle-income countries grew by less than 2 percent, totaling US$8.64 billion in 2014. After adjusting for inflation and exchange rate changes, the increase was marginal (1%).
The report focuses on Kenya’s reclassification from a low-income country (LIC) to a lower-middle-income country (LMIC) exploring in particular the implications on health financing of the reclassification. Moving towards universal healthcare (UHC) is an ambition recognized in Kenya’s constitution and the report explores ways in which finance could be increased to achieve this goal.
Against all odds, the AIDS targets of Millennium Development Goal 6 have been reached. AIDS changed everything. As of March 2015, 15 million people living with HIV were accessing antiretroviral therapy, up from 13.6 million in June 2014.
After more than a decade of major achievements, the AIDS response is at a crucial juncture, both in terms of its immediate trajectory and its sustainability, as well as its place in the new global health and development agendas.
Cuba became the first country in the world to receive validation from the World Health Organization (WHO) that it has eliminated mother-to-child transmission of HIV and syphilis.
Speaking at the 2015 Western Regional HIV and AIDS Scientific Conference, Dr Zepher Karyabakabo, director of policy, research and programming at Uganda AIDS Commission, said Uganda has 1.6 million people living with HIV who need care, treatment and support. He added that 56,000 people die every year of HIV-related illnesses.
The Trans Pacific Partnership continues a pattern of incrementally increasing intellectual property protections for pharmaceuticals beyond those enshrined in recently negotiated free trade agreements. These repeated measures to extend IP protections result in a decline in generic competition and an increase in drug costs for those who can least afford them, and set dangerous precedents for future FTAs.
The world is engaged in intense negotiations that have already yielded the scaffolding of a new development framework. With 17 tentative goals and over 150 indicators to measure them, policy-makers with limited resources will have to make difficult decisions about which ones to prioritize. History teaches us that they will be tempted to scuttle sexual and reproductive rights off to the side because contraception and safe legal abortion seem too sensitive or politically risky (in 2001, family planning and reproductive health were initially left out of the Millennium Development Goals). They must choose a better a way forward.
Although there may be responsibility on the part of individuals for the way in which the response to the Ebola outbreak has been handled, it is necessary to identify and correct the structural causes of any shortcomings. In doing so, it must be recognized that there is an increasingly complex nexus of health, humanitarian and security crises that requires the United Nations system to find new approaches that go beyond institutional silos.